IRIS
SCAVONE, Cristina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.650
NA - Nord America 3.716
AS - Asia 2.405
SA - Sud America 477
Continente sconosciuto - Info sul continente non disponibili 202
AF - Africa 35
OC - Oceania 2
Totale 12.487
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 3.813
US - Stati Uniti d'America 3.561
SG - Singapore 853
IT - Italia 570
IE - Irlanda 529
CN - Cina 460
BR - Brasile 400
VN - Vietnam 369
HK - Hong Kong 329
GB - Regno Unito 201
DE - Germania 181
KR - Corea 99
UA - Ucraina 85
CA - Canada 71
IN - India 71
JP - Giappone 68
GR - Grecia 48
BD - Bangladesh 37
FI - Finlandia 34
TR - Turchia 30
FR - Francia 29
AR - Argentina 27
SE - Svezia 21
ES - Italia 20
EC - Ecuador 18
ID - Indonesia 16
MX - Messico 16
NL - Olanda 16
AT - Austria 15
PL - Polonia 15
CZ - Repubblica Ceca 12
ZA - Sudafrica 12
BE - Belgio 11
CO - Colombia 11
CR - Costa Rica 11
IQ - Iraq 11
SV - El Salvador 11
SC - Seychelles 10
VE - Venezuela 10
TT - Trinidad e Tobago 9
UZ - Uzbekistan 9
SA - Arabia Saudita 8
AL - Albania 7
GP - Guadalupe 7
PK - Pakistan 7
CH - Svizzera 6
CW - ???statistics.table.value.countryCode.CW??? 6
HN - Honduras 6
JM - Giamaica 6
NI - Nicaragua 6
CL - Cile 5
IR - Iran 5
LT - Lituania 5
DK - Danimarca 4
EE - Estonia 4
HU - Ungheria 4
KG - Kirghizistan 4
NP - Nepal 4
PR - Porto Rico 4
PY - Paraguay 4
RO - Romania 4
RS - Serbia 4
AE - Emirati Arabi Uniti 3
BB - Barbados 3
BG - Bulgaria 3
EG - Egitto 3
GT - Guatemala 3
MA - Marocco 3
TN - Tunisia 3
EU - Europa 2
GE - Georgia 2
IL - Israele 2
JO - Giordania 2
KE - Kenya 2
KW - Kuwait 2
LV - Lettonia 2
MD - Moldavia 2
MY - Malesia 2
NO - Norvegia 2
PE - Perù 2
PH - Filippine 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
AM - Armenia 1
AU - Australia 1
BH - Bahrain 1
BS - Bahamas 1
DO - Repubblica Dominicana 1
GA - Gabon 1
HR - Croazia 1
IS - Islanda 1
KI - Kiribati 1
LA - Repubblica Popolare Democratica del Laos 1
NG - Nigeria 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
Totale 12.293
Salva come PNG Salva come JPEG
Città #
Moscow 1.370
Dublin 525
San Jose 513
Singapore 415
Ashburn 384
Santa Clara 352
Hong Kong 324
Chandler 195
Council Bluffs 182
Jacksonville 159
Ho Chi Minh City 101
Seoul 97
Dallas 95
Beijing 78
Hanoi 71
Bremen 70
New York 69
Princeton 69
Roxbury 69
Los Angeles 68
Milan 65
Hefei 63
Dong Ket 60
Medford 46
São Paulo 41
Ann Arbor 38
Aversa 38
The Dalles 37
Naples 36
Caserta 34
Munich 30
Orem 30
San Francisco 30
Bengaluru 28
Atlanta 27
Denver 26
Memphis 25
Rome 25
Wilmington 25
Cambridge 24
Napoli 24
Chicago 22
Da Nang 19
Montreal 19
Toronto 19
Woodbridge 18
Brooklyn 17
Des Moines 17
Rio de Janeiro 16
London 15
Nuremberg 14
Phoenix 13
Miano 12
Nanjing 12
Salerno 12
Brno 11
Brussels 11
Falkenstein 11
Hanover 11
Helsinki 11
Chennai 10
Mexico City 10
Phủ Lý 10
Amsterdam 9
Boston 9
Johannesburg 9
Manchester 9
Mountain View 9
San Salvador 9
Biên Hòa 8
Brasília 8
Haiphong 8
Hải Dương 8
Jinan 8
Messina 8
Tashkent 8
Tokyo 8
Vienna 8
Warsaw 8
Changsha 7
Columbus 7
Curitiba 7
Guangzhou 7
Jakarta 7
Newark 7
Norwalk 7
San José 7
Turku 7
Boardman 6
Bologna 6
Charlotte 6
Düsseldorf 6
Frankfurt am Main 6
Kunming 6
Managua 6
Piracicaba 6
Redwood City 6
Stockholm 6
Willemstad 6
Auburn Hills 5
Totale 6.536
Salva come PNG Salva come JPEG
Nome #
Hyponatremia following Antipsychotic Treatment: In Silico Pharmacodynamics Analysis of Spontaneous Reports from the US Food and Drug Administration Adverse Event Reporting System Database and an Updated Systematic Review 571
Amelioration of diastolic dysfunction by dapagliflozin in a non-diabetic model involves coronary endothelium 203
Campania Region (Italy) spontaneous reporting system and preventability assessment through a case-by-case approach: a pilot study on psychotropic drugs 196
Safety profile of anticancer and immune-modulating biotech drugs used in a real world setting in Campania Region (Italy): BIO-Cam observational study 191
Contrast media-induced nephropathy: how has Italy contributed in the past 30 years? A systematic review 191
Angiotensin II and angiotensin 1-7: which is their role in atrial fibrillation? 189
Campania preventability assessment committee (Italy): A focus on the preventability of non-steroidal anti-inflammatory drugs' adverse drug reactions 188
Antidepressant-Induced Acute Liver Injury: A Case-Control Study in an Italian Inpatient Population 185
Campania preventability assessment committee: a focus on the preventability of the contrast media adverse drug reactions 178
Dipeptidyl Peptidase 4 Inhibition Ameliorates Chronic Kidney Disease in a Model of Salt-Dependent Hypertension 177
Comparison of long-term clinical implications of beta-blockade in patients with obstructive airway diseases exposed to beta-blockers with different β1-adrenoreceptor selectivity: An Italian population-based cohort study 176
Medication adherence and the use of new pharmaceutical formulations: The case of levothyroxine 172
Atomoxetine in the treatment of attention deficit hyperactivity disorder and suicidal ideation 168
Adverse drug reactions during hepatitis C treatment with direct-acting antivirals: The role of medication errors, their impact on treatment discontinuation and their preventability. New insights from the Campania Region (Italy) spontaneous reporting system 165
Association between the glyco-metabolic adverse effects of antipsychotic drugs and their chemical and pharmacological profile: A network meta-analysis and regression 164
Biosimilars in the European Union from comparability exercise to real world experience: What we achieved and what we still need to achieve 162
Pregnancy Recommendations Solely Based on Preclinical Evidence Should Be Integrated with Real-World Evidence: A Disproportionality Analysis of Certolizumab and Other TNF-Alpha Inhibitors Used in Pregnant Patients with Psoriasis 161
The Potential Benefits of a Novel Food Supplement Based on Cannabis Sativa, Boswellia, and Fish Oil for Pain and Inflammation in Physical Activity: Unraveling the Role of Orexin-A Modulation 158
Effects of ranolazine in a model of doxorubicin-induced left ventricle diastolic dysfunction 157
Cardiac Events Potentially Associated to Remdesivir: An Analysis from the European Spontaneous Adverse Event Reporting System 157
Hypogammaglobulinemia in patients with multiple sclerosis receiving disease modifying therapies: disproportionality analysis using the EudraVigilance database 155
Did the new Italian law on mandatory vaccines affect adverse event Following immunization's reporting? A pharmacovigilance study in Southern Italy 154
Can causality assessment fulfill the new European definition of adverse drug reaction? A review of methods used in spontaneous reporting( 153
Neurological Manifestations Related to Immune Checkpoint Inhibitors: Reverse Translational Research by Using the European Real-World Safety Data 152
Correction to: Angiotensin II and angiotensin 1–7: which is their role in atrial fibrillation? (Heart Failure Reviews, (2020), 10.1007/s10741-020-09961-9) 150
Current pharmacological treatments for COVID-19: What's next? 146
Skin Toxicities Associated with Botulin Toxin Injection for Aesthetic Procedures: Data from the European Spontaneous Reporting System 145
Disclosing negative trial results – procedure 143
The importance of Pharmacovigilance for the drug safety: Focus on cardiovascular profile of incretin-based therapy 142
Hepatobiliary Adverse Reactions during Treatment with Cladribine: Analysis of Data from the European Spontaneous Reporting System 139
Mid-term follow-up after COVID-19 vaccination in adults with CHD: a prospective study 138
Lymphopenia associated with sphingosine 1-phosphate receptor modulators (S1PRMs) in multiple sclerosis: analysis of European pharmacovigilance data 137
Changes in Anthropometric Parameters After Anti-TNFα Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis 137
The Use of Botulinum Toxin Type A and the Occurrence of Anaphylaxis: A Descriptive Analysis of Data from the European Spontaneous Reporting System 136
T-cell malignancies following CAR T-Cell therapy: insights from the FDA Adverse Event Reporting System (FAERS) 136
Blood-based PD-L1 analysis in tumor-derived extracellular vesicles: Applications for optimal use of anti-PD-1/PD-L1 axis inhibitors 133
The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19 132
Disproportionality analysis of European safety reports on autoimmune and rheumatic diseases following COVID-19 vaccination 130
Disclosure of negative trial results. A call for action 130
The Safety Profile of COVID-19 Vaccines in Patients Diagnosed with Multiple Sclerosis: A Retrospective Observational Study 129
Safety of dapagliflozin and empagliflozin in cases with diabetes mellitus or/and heart failure: a retrospective pharmacovigilance study conducted on the eudravigilance database 128
Comparison of injective related reactions following ofatumumab and ocrelizumab in patients with multiple sclerosis: data from the European spontaneous reporting system 128
Immune Checkpoint Inhibitors and Immune-Related Adverse Drug Reactions: Data From Italian Pharmacovigilance Database 127
Immune Checkpoint Inhibitors and Cardiotoxicity: An Analysis of Spontaneous Reports in Eudravigilance 126
Efficacy and safety of insulin-GLP-1 receptor agonists combination in type 2 diabetes mellitus: a systematic review 125
Combining liquid biopsy and radiomics for personalized treatment of lung cancer patients. State of the art and new perspectives 125
Gender differences in outpatient pediatric drug utilization: A cohort study from southern Italy 124
PCSK9 Inhibitors and Neurocognitive Adverse Drug Reactions: Analysis of Individual Case Safety Reports from the Eudravigilance Database 123
Influenza vaccine hesitancy in patients with multiple sclerosis: A monocentric observational study 123
New era in treatment options of chronic hepatitis C: focus on safety of new direct-acting antivirals (DAAs) 121
Parental vaccine hesitancy: Recent evidences support the need to implement targeted communication strategies 120
Severe Multiple Sclerosis Relapse After COVID-19 Vaccination: A Case Report 119
Disease-modifying therapies and hematological disorders: a systematic review of case reports and case series 118
Drugs approved for the treatment of multiple sclerosis: review of their safety profile 117
Therapeutic strategies to fight COVID-19: Which is the status artis? 117
Surveillance of adverse events following immunization related to human papillomavirus vaccines: 12 years of vaccinovigilance in Southern Italy 116
Renin-angiotensin system and coronavirus disease 2019: A narrative review 116
Preventable statin adverse reactions and therapy discontinuation. What can we learn from the spontaneous reporting system? 115
Pillars and Pitfalls of the New Pharmacovigilance legislation: Consequences for the identification of adverse drug reactions deriving from abuse, misuse, overdose, occupational exposure, and medication errors 114
Drugs-induced pathological gambling: An analysis of italian spontaneous reporting system 114
No substantial gender differences in suspected adverse reactions to ACE inhibitors and ARBs: results from spontaneous reporting system in Campania Region 113
Strengths, weaknesses and future challenges of biosimilars’ development. An opinion on how to improve the knowledge and use of biosimilars in clinical practice 113
Two Unexpected Cases of Rosacea during Fingolimod Therapy 113
Three Doses of COVID-19 Vaccines: A Retrospective Study Evaluating the Safety and the Immune Response in Patients with Multiple Sclerosis 113
New and old roles of the peripheral and brain renin–angiotensin–aldosterone system (RAAS): Focus on cardiovascular and neurological diseases 112
Safety of Anticancer Agents Used in Children: A Focus on Their Off-Label Use Through Data From the Spontaneous Reporting System 112
Mineralocorticoid receptor antagonists in heart failure with preserved ejection fraction (HFpEF) 111
Quinolones-Induced Musculoskeletal, Neurological, and Psychiatric ADRs: A Pharmacovigilance Study Based on Data From the Italian Spontaneous Reporting System 109
Tisagenlecleucel in children and young adults: Reverse translational research by using real‐world safety data 109
Preventable cases of oral anticoagulant-induced bleeding: Data from the spontaneous reporting system 106
Weight and body mass index increase in children and adolescents exposed to antipsychotic drugs in non-interventional settings: a meta-analysis and meta-regression 106
Anti-hypertensive drugs deprescribing: an updated systematic review of clinical trials 106
The European clinical trials regulation (No 536/2014): changes and challenges 105
SGLT-2 inhibitors reduce the risk of cerebrovascular/cardiovascular outcomes and mortality: A systematic review and meta-analysis of retrospective cohort studies 105
The expanding family of c-Met inhibitors in solid tumors: a comparative analysis of their pharmacologic and clinical differences 104
Suspected adverse reactions to contrast media in Campania Region (Italy): Results from 14 years of post-marketing surveillance 103
Hypernatremia During Intravenous Treatment With Fosfomycin: A Retrospective Medical Record Review Study and an Analysis of Spontaneous Reports in the EudraVigilance Database 101
Response to the comment “Is SGLT2i superior to DPP4i for primary and secondary prevention of cardiovascular diseases and death in patients with type 2 diabetes?” 100
Efficacy and Safety Profile of Diclofenac/Cyclodextrin and Progesterone/Cyclodextrin Formulations: A Review of the Literature Data 99
NSAIDs in patients with viral infections, including Covid-19: Victims or perpetrators? 99
SMS-Based Active Surveillance of Adverse Events following Immunization in Children: The VigiVax Study 98
Real World Data on the Utilization Pattern and Safety Profile of Infliximab Originator Versus Biosimilars in Italy: A Multiregional Study 98
Vaccine Hesitancy Among Religious Groups: Reasons Underlying This Phenomenon and Communication Strategies to Rebuild Trust 97
Response to the comment on “SGLT-2 inhibitors reduce the risk of cerebrovascular/cardiovascular outcomes and mortality: A systematic review and meta-analysis of retrospective cohort studies” 97
Severe Cutaneous Adverse Drug Reactions Associated with Allopurinol: An Analysis of Spontaneous Reporting System in Southern Italy 96
Italian immunization goals: A political or scientific heated debate? 95
Predictors of new oral anticoagulant drug initiation as opposed to warfarin in elderly adults: A retrospective observational study in Southern Italy 94
The New Paradigms in Clinical Research: From Early Access Programs to the Novel Therapeutic Approaches for Unmet Medical Needs. 91
On the Policy of the Italian Government in the Discovery, Development, and Access to Medicines 88
SARS-Cov-2 infection: Response of human immune system and possible implications for the rapid test and treatment 86
The safety profile of general and local anaesthetic agents: Data collected during 20 years of spontaneous reporting activities in the campania region (southern italy) 86
Flu vaccination in multiple sclerosis patients: a monocentric prospective vaccine-vigilance study 57
Hepatobiliary disorders and Direct-Acting Antiviral (DAA) therapies: real-world evidence and insights from the EudraVigilance database 46
Facts and figures of the compassionate use of onco-hematological drugs from 2016 to 2021: Results from the multicentric observational study Compass-O 35
Major Adverse Cardiovascular Events Related to JAK Inhibitors: A Disproportionality Analysis Using the WHO Global Individual Case Safety Database 24
null 18
Totale 12.487
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.719
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.719
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022380 0 0 0 5 126 13 19 14 21 18 23 141
2022/2023981 134 36 18 60 107 59 6 47 467 4 25 18
2023/2024407 24 3 15 13 135 13 7 72 12 3 34 76
2024/20251.413 6 21 20 32 204 178 238 116 223 127 131 117
2025/20266.640 285 305 315 358 562 3.524 254 372 239 236 121 69
2026/20271.693 404 168 533 588 0 0 0 0 0 0 0 0
Totale 12.487